SBC Medical Group Holdings Incorporated Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
SBC Medical Group Holdings Incorporated (SBC) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $184.31 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $184.31M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $167.31M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $163.77M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $127.43M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations as first filed |
|---|---|---|
| 2026-06-30 | $184.31M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $167.31M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $163.77M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $127.43M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $152.74M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $132.06M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $125.04M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $137.39M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $103.70M 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $96.18M 10-Q · filed 2025-05-15 | $1.66M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $103.02M 10-K · filed 2026-03-27 | $284.39K 10-K · filed 2024-03-19 |
| 2023-09-30 | $77.43M 10-Q · filed 2024-11-13 | $574.34K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $974.92K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $217.35K 10-Q · filed 2024-05-20 | |
| 2022-12-31 | $51.74M 10-K · filed 2025-03-28 | $485.56K 10-K · filed 2023-03-09 |
| 2022-09-30 | $579.97K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $179.43K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |